Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
KRAS G12C-mutated Non-Small Cell Lung Cancer and advanced Colorectal Cancer.
Hodgkin Lymphoma, CD30-expressing T-cell lymphomas, Urothelial Carcinoma, Cervical Cancer, or Diffuse Large B-cell Lymphoma.
HER2-positive or HER2-low metastatic Breast Cancer, HER2-mutant Non-Small Cell Lung Cancer, and Gastric Adenocarcinoma.
Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.
Approved for use in oncology care according to FDA-approved indications.
Relapsed or refractory B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma, or Multiple Myeloma.
EGFR-mutated Non-Small Cell Lung Cancer (NSCLC).
Approved for use in oncology care according to FDA-approved indications.
Deleterious BRCA-mutated or HRD-positive Ovarian, Breast, Pancreatic, and Prostate Cancers.
Prevention and management of chemotherapy-induced and radiation-induced nausea and vomiting (CINV).
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.